What is Vericel Corp (VCEL)?
Vericel Corporation is a biotechnology company specializing in the development and commercialization of advanced cell therapies for the treatment of severe diseases and conditions. The company focuses on regenerative medicine products that address unmet medical needs in areas such as sports medicine and severe burns. Its product portfolio includes autologous cell therapies designed to promote tissue repair and healing. Vericel Corporation engages in research and development activities to expand its pipeline and improve therapeutic options. The company collaborates with healthcare providers and regulatory agencies to advance clinical applications of its technologies. Operating within the biopharmaceutical sector, Vericel contributes to innovations in personalized medicine and regenerative treatments aimed at improving patient outcomes.
Vericel Corp Stock Price Today: Live Overview
The price today is shaped by current trading conditions, as Vericel Corp is priced at $31.51. The stock traded between $30.6 and $33.45, marking a daily change of -5.8503%.
FAQ: Vericel Corp (VCEL)
What is the current price of VCEL stock?
The current price stands at $31.51.
Does VCEL pay dividends?
Vericel Corp does not pay dividends.
Does VCEL have a formal corporate presence or regional headquarters in the UAE?
Vericel Corp does not have an official presence or subsidiary in the UAE and operates through distributors.
What is VCEL best known for?
Vericel Corp is most famous for its regenerative medicine products for sports injuries.
What assets are typically shown together with VCEL?
Commonly shown alongside VCEL: Atos, Accelerant Holdings, Polymetals Resources Limited
Latest shares articles



